Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021)

Autor: Alexandre Godon, Charles Ambroise Tacquard, Alexandre Mansour, Delphine Garrigue, Philippe Nguyen, Dominique Lasne, Sophie Testa, Jerrold H. Levy, Pierre Albaladejo, Yves Gruel, Sophie Susen, Anne Godier, P. Albaladejo, N. Blais, F. Bonhomme, A. Borel-Derlon, A. Cohen, J.-P. Collet, E. de Maistre, P. Fontana, D. Garrigue Huet, A. Godier, Y. Gruel, A. Godon, B. Ickx, S. Laporte, D. Lasne, J. Llau, G. Le Gal, T. Lecompte, S. Lessire, J.H. Levy, D. Longrois, S. Madi-Jebara, A. Mansour, M. Mazighi, P. Mismetti, P.E. Morange, S. Motte, F. Mullier, N. Nathan, P. Nguyen, G. Pernod, N. Rosencher, S. Roullet, P.M. Roy, S. Schlumberger, P. Sié, A. Steib, S. Susen, C.A. Tacquard, S. Testa, A. Vincentelli, P. Zufferey, E Boissier, B Dumont, C James, V. Siguret

Publikováno v: Anaesthesia, Critical Care & Pain Medicine
Anaesthesia Critical Care & Pain Medicine
Anaesthesia Critical Care & Pain Medicine, 2021, 40 (4), pp.100919. ⟨10.1016/j.accpm.2021.100919⟩

In April 2020, in response to the high thrombotic risk associated with COVID-19, the GIHP and GFHT published proposals for the prevention of venous thromboembolism (VTE) and haemostasis monitoring in patients with COVID-19 [1]. In February 2021, six

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a583d692b70a44d74c2af2ba2b7db7c
http://europepmc.org/articles/PMC8233055

Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia

Autor: Charles Tacquard, Alexandre Mansour, Alexandre Godon, Julien Godet, Julien Poissy, Delphine Garrigue, Eric Kipnis, Sophie Rym Hamada, Paul Michel Mertes, Annick Steib, Mathilde Ulliel-Roche, Bélaïd Bouhemad, Maxime Nguyen, Florian Reizine, Isabelle Gouin-Thibault, Marie Charlotte Besse, Nived Collercandy, Stefan Mankikian, Jerrold H. Levy, Yves Gruel, Pierre Albaladejo, Sophie Susen, Anne Godier, P. Albaladejo, N. Blais, F. Bonhomme, A. Borel-Derlon, A. Cohen, J.-P. Collet, E. de Maistre, P. Fontana, D. Garrigue Huet, A. Godier, Y. Gruel, A. Godon, B. Ickx, S. Laporte, D. Lasne, J. Llau, G. Le Gal, T. Lecompte, S. Lessire, J.H. Levy, D. Longrois, S. Madi-Jebara, A. Mansour, M. Mazighi, P. Mismetti, P.E. Morange, S. Motte, F. Mullier, N. Nathan, P. Nguyen, G. Pernod, N. Rosencher, S. Roullet, P.M. Roy, S. Schlumberger, P. Sié, A. Steib, S. Susen, C.A. Tacquard, S. Testa, A. Vincentelli, P. Zufferey

Publikováno v: Chest
Chest, American College of Chest Physicians, 2021, 159 (6), pp.2417-2427. ⟨10.1016/j.chest.2021.01.017⟩
Chest, 2021, 159 (6), pp.2417-2427. ⟨10.1016/j.chest.2021.01.017⟩

International audience; BACKGROUND: Because of the high risk of thrombotic complications (TCs) during SARS-CoV-2 infection, several scientific societies have proposed to increase the dose of preventive anticoagulation, although arguments in favor of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5774e2837775de881a1bad179fbcdf3
https://hal.archives-ouvertes.fr/hal-03285114

Diagnosis and management of heparin-induced thrombocytopenia

Autor: Yves Ozier, F. Mullier, P. Albaladejo, Grégoire Le Gal, Jean-François Schved, Sophie Susen, Jean-Philippe Collet, Emmanuel Marret, Yves Gruel, Jean-François Hardy, Claire Pouplard, N. Blais, D. Lasne, Sylvie Schlumberger, Thomas Lecompte, A. Vincentelli, J.Y. Borg, Brigitte Ickx, A. Godier, Guy Meyer, E de Maistre, Dan Longrois, Samia Madi-Jebara, Sophie Testa, Nathalie Nathan, Mikael Mazighi, André Vincentelli, Joanne Guay, S. Laporte, P.M. Roy, Emmanuel de Maistre, D. Garrigue Huet, P. Zufferey, Y. Huet, Nadia Rosencher, P. Van der Linden, Dominique Lasne, S. Roullet, Y. Gruel, François Mullier, P. Sié, Philippe Nguyen, David Faraoni, Normand Blais, Jerrold H. Levy, Annick Steib, P.E. Morange, S. Lessire, G. Le Gal, Juan V. Llau, Anne Godier, Sylvain Bélisle, Pierre Albaladejo, Serge Motte, Stéphanie Roullet, J.-L. Bosson, Patrick Mismetti, Fanny Bonhomme, Charles-Marc Samama, E. van Belle, J.L. Mas, Pierre Fontana, G. Pernod, S. Susen, A. Borel-Derlon, A. Cohen

Publikováno v: Anaesthesia, critical care & pain medicine, Vol. 39, no. 2, p. 291-310 (2020)
Anaesthesia Critical Care & Pain Medicine
Anaesthesia Critical Care & Pain Medicine, In press, 39 (2), pp.291-310. ⟨10.1016/j.accpm.2020.03.012⟩

Heparin-induced thrombocytopenia (HIT) is a rare, iatrogenic disease characterised by its potential severity, mainly related to thrombosis, and by difficulties regarding its diagnosis and management of affected patients. In 2002, a conference of expe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80221eca6088c821e18fe0f4c77306d8
https://hdl.handle.net/2078.1/229649

Tiempo de Quick (tasa de protrombina), INR

Autor: M F Hurtaud, E de Maistre, Isabelle Gouin-Thibault, Virginie Siguret, Georges Jourdi, L Calmette

Publikováno v: EMC - Tratado de Medicina. 21:1-7

El tiempo de Quick es una prueba semiglobal de la coagulacion que permite estudiar ex vivo los factores de la via del factor tisular, tambien denominada via extrinseca de la coagulacion (factores VII, X, V, II y fibrinogeno). El resultado del tiempo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1e82954121cac2bcd2b3a83d7b043d28
https://doi.org/10.1016/s1636-5410(17)86938-5